Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-113219·Cogent Biosciences, Inc.
Schedule 13D ownership disclosure
COGENT BIOSCIENCES INC
Common Stock, $0.001 par value · CUSIP: 19240Q201
Event date: 2025-11-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Fairmount Funds Management LLCReported CIK 0001802528
Shares: 15,877,418.00 · Class: 9.9%
- Fairmount Healthcare Fund II GP LLCReported CIK 0001830382
Shares: 15,877,418.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-113219
- Form type
- SCHEDULE 13D/A
- Filer
- Cogent Biosciences, Inc.
- CIK
- CIK 1622229
- Filed
- Nov 17, 2025
- Reporting period
- Nov 13, 2025
- Description
- Schedule 13D beneficial ownership